Novel Techniques to Prevent Apoptosis and Improve Regeneration in Corneal Endothelial Cells

Guo-Jian Jiang,Ting-Jun Fan

DOI: https://doi.org/10.1080/17469899.2020.1794821

2020-01-01

Expert Review of Ophthalmology

Abstract:Introduction: Human corneal endothelial cells (HCECs) play pivotal roles in maintaining corneal transparency, integrity, and thickness. However, their proliferation ceases in a mature human corneal endothelium. Thus, excessive loss of HCECs will result in decompensation of the corneal endothelium, which leads to corneal edema and visual loss eventually. Therefore, finding ways to inhibit apoptosis in HCECs is urgent for both clinical and basic research in ophthalmology. Areas covered: The apoptotic mechanism of HCEC due to disease, eye drop, and ultraviolet A (UVA) with corresponding strategies and techniques to inhibit the apoptosis in the HCECs. Expert opinion: The suitable treatment for Fuchs endothelial corneal dystrophy is to inject antioxidants directly or combined with anesthetic agent into anterior chamber during the ophthalmic surgery and administrate antibiotics and Stat3 activator post-operatively to prevent inflammation and apoptosis. Moreover, antioxidants, ROCK inhibitor, transgenic techniques, and apoptotic antagonists can be employed to interrupt the critical sections of intrinsic and extrinsic apoptotic pathways activated by eyedrop or UVA. These methods exhibit great promise inin vitroand animal studies, but so far none of these approaches has been shown to be safe and effective for prevention of apoptosis in human clinical trials.